APO Research
Talk to an analyst

APO RESEARCH · REPORT

Rifaximin Capsules

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Rifaximin Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025186 pages

Choose your research edition.

Industry ResearchRifaximin Capsules Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Rifaximin Capsules Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Rifaximin Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rifaximin Capsules Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Rifaximin Capsules Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Rifaximin Capsules market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Rifaximin Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Rifaximin Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Rifaximin Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Rifaximin Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Rifaximin Capsules include Aden Healthcare, Alfasigma SpA, Estrellas Life Sciences Private Limited, Hainan Hailing Chemical Pharmaceutical Co., Ltd., Hainan Sanye Pharmaceutical Factory Co., Ltd., Shanghai Xinya Pharmaceutical Minhang Co., Ltd. and Southwest Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Rifaximin Capsules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Rifaximin Capsules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Rifaximin Capsules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Rifaximin Capsules market size, projected growth trends, production technologies, key applications, and end-use industries.

Rifaximin Capsules Segment by Company

Aden Healthcare

Alfasigma SpA

Estrellas Life Sciences Private Limited

Hainan Hailing Chemical Pharmaceutical Co., Ltd.

Hainan Sanye Pharmaceutical Factory Co., Ltd.

Shanghai Xinya Pharmaceutical Minhang Co., Ltd.

Southwest Pharmaceutical Co., Ltd.

Rifaximin Capsules Segment by Type

0.1g

0.2g

Rifaximin Capsules Segment by Application

Hospital

Clinic

Other

Rifaximin Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rifaximin Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rifaximin Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rifaximin Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Rifaximin Capsules market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Rifaximin Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Rifaximin Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Rifaximin Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Rifaximin Capsules Industry Trends Table 2. Rifaximin Capsules Industry Drivers Table 3. Rifaximin Capsules Industry Opportunities and Challenges Table 4. Rifaximin Capsules Industry Restraints Table 5. Global Rifaximin Capsules Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Rifaximin Capsules Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Rifaximin Capsules Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Rifaximin Capsules Sales Market Share by Manufacturers Table 9. Global Rifaximin Capsules Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Rifaximin Capsules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Rifaximin Capsules Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Rifaximin Capsules Manufacturers, Product Type & Application Table 13. Global Rifaximin Capsules Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Rifaximin Capsules by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 0.1g Table 17. Major Manufacturers of 0.2g Table 18. Global Rifaximin Capsules Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Rifaximin Capsules Sales by Type (2021-2026) & (K Units) Table 20. Global Rifaximin Capsules Sales by Type (2027-2032) & (K Units) Table 21. Global Rifaximin Capsules Sales Market Share by Type (2021-2026) Table 22. Global Rifaximin Capsules Sales Market Share by Type (2027-2032) Table 23. Global Rifaximin Capsules Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Rifaximin Capsules Revenue by Type (2021-2026) & (K Units) Table 25. Global Rifaximin Capsules Revenue by Type (2027-2032) & (K Units) Table 26. Global Rifaximin Capsules Revenue Market Share by Type (2021-2026) Table 27. Global Rifaximin Capsules Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Other Table 31. Global Rifaximin Capsules Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Rifaximin Capsules Sales by Application (2021-2026) & (K Units) Table 33. Global Rifaximin Capsules Sales by Application (2027-2032) & (K Units) Table 34. Global Rifaximin Capsules Sales Market Share by Application (2021-2026) Table 35. Global Rifaximin Capsules Sales Market Share by Application (2027-2032) Table 36. Global Rifaximin Capsules Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Rifaximin Capsules Revenue by Application (2021-2026) & (K Units) Table 38. Global Rifaximin Capsules Revenue by Application (2027-2032) & (K Units) Table 39. Global Rifaximin Capsules Revenue Market Share by Application (2021-2026) Table 40. Global Rifaximin Capsules Revenue Market Share by Application (2027-2032) Table 41. Global Rifaximin Capsules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Rifaximin Capsules Sales by Region (2021-2026) & (K Units) Table 43. Global Rifaximin Capsules Sales Market Share by Region (2021-2026) Table 44. Global Rifaximin Capsules Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Rifaximin Capsules Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Rifaximin Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Rifaximin Capsules Sales by Country (2021-2026) & (K Units) Table 48. North America Rifaximin Capsules Sales by Country (2027-2032) & (K Units) Table 49. Europe Rifaximin Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Rifaximin Capsules Sales by Country (2021-2026) & (K Units) Table 51. Europe Rifaximin Capsules Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Rifaximin Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Rifaximin Capsules Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Rifaximin Capsules Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Rifaximin Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Rifaximin Capsules Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Rifaximin Capsules Sales by Country (2027-2032) & (K Units) Table 58. Global Rifaximin Capsules Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Rifaximin Capsules Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Rifaximin Capsules Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Rifaximin Capsules Revenue Market Share by Region (2021-2026) Table 62. Global Rifaximin Capsules Revenue Market Share by Region (2027-2032) Table 63. Aden Healthcare Company Information Table 64. Aden Healthcare Business Overview Table 65. Aden Healthcare Rifaximin Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Aden Healthcare Rifaximin Capsules Product Portfolio Table 67. Aden Healthcare Recent Development Table 68. Alfasigma SpA Company Information Table 69. Alfasigma SpA Business Overview Table 70. Alfasigma SpA Rifaximin Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Alfasigma SpA Rifaximin Capsules Product Portfolio Table 72. Alfasigma SpA Recent Development Table 73. Estrellas Life Sciences Private Limited Company Information Table 74. Estrellas Life Sciences Private Limited Business Overview Table 75. Estrellas Life Sciences Private Limited Rifaximin Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Estrellas Life Sciences Private Limited Rifaximin Capsules Product Portfolio Table 77. Estrellas Life Sciences Private Limited Recent Development Table 78. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Company Information Table 79. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Business Overview Table 80. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Rifaximin Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Rifaximin Capsules Product Portfolio Table 82. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Recent Development Table 83. Hainan Sanye Pharmaceutical Factory Co., Ltd. Company Information Table 84. Hainan Sanye Pharmaceutical Factory Co., Ltd. Business Overview Table 85. Hainan Sanye Pharmaceutical Factory Co., Ltd. Rifaximin Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Hainan Sanye Pharmaceutical Factory Co., Ltd. Rifaximin Capsules Product Portfolio Table 87. Hainan Sanye Pharmaceutical Factory Co., Ltd. Recent Development Table 88. Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Company Information Table 89. Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Business Overview Table 90. Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Rifaximin Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Rifaximin Capsules Product Portfolio Table 92. Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Recent Development Table 93. Southwest Pharmaceutical Co., Ltd. Company Information Table 94. Southwest Pharmaceutical Co., Ltd. Business Overview Table 95. Southwest Pharmaceutical Co., Ltd. Rifaximin Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Southwest Pharmaceutical Co., Ltd. Rifaximin Capsules Product Portfolio Table 97. Southwest Pharmaceutical Co., Ltd. Recent Development Table 98. Key Raw Materials Table 99. Raw Materials Key Suppliers Table 100. Rifaximin Capsules Distributors List Table 101. Rifaximin Capsules Customers List Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. Rifaximin Capsules Product Image Figure 2. Global Rifaximin Capsules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rifaximin Capsules Market Size (2021-2032) & (US$ Million) Figure 4. Global Rifaximin Capsules Sales (2021-2032) & (K Units) Figure 5. Global Rifaximin Capsules Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Rifaximin Capsules Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 0.1g Image Figure 9. 0.2g Image Figure 10. Global Rifaximin Capsules Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Rifaximin Capsules Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Rifaximin Capsules Sales Market Share by Type (2021-2032) Figure 13. Global Rifaximin Capsules Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Rifaximin Capsules Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Rifaximin Capsules Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Other Image Figure 19. Global Rifaximin Capsules Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Rifaximin Capsules Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Rifaximin Capsules Sales Market Share by Application (2021-2032) Figure 22. Global Rifaximin Capsules Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Rifaximin Capsules Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Rifaximin Capsules Revenue Market Share by Application (2021-2032) Figure 25. North America Rifaximin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Rifaximin Capsules Sales Market Share by Country (2021-2032) Figure 27. U.S. Rifaximin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Rifaximin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Rifaximin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Rifaximin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Rifaximin Capsules Sales Market Share by Country (2021-2032) Figure 32. Germany Rifaximin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Rifaximin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Rifaximin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Rifaximin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Rifaximin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Rifaximin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Rifaximin Capsules Sales Market Share by Country (2021-2032) Figure 39. China Rifaximin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Rifaximin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Rifaximin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Rifaximin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Rifaximin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Rifaximin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Rifaximin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Rifaximin Capsules Sales Market Share by Country (2021-2032) Figure 47. Brazil Rifaximin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Rifaximin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Rifaximin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Rifaximin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Rifaximin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Rifaximin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Rifaximin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Rifaximin Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Rifaximin Capsules Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Rifaximin Capsules Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Rifaximin Capsules Revenue (2021-2032) & (US$ Million) Figure 58. North America Rifaximin Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Rifaximin Capsules Revenue (2021-2032) & (US$ Million) Figure 60. Europe Rifaximin Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Rifaximin Capsules Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Rifaximin Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Rifaximin Capsules Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Rifaximin Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Rifaximin Capsules Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Rifaximin Capsules Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 0.1g
  • 0.2g
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Aden Healthcare
  • Alfasigma SpA
  • Estrellas Life Sciences Private Limited
  • Hainan Hailing Chemical Pharmaceutical Co., Ltd.
  • Hainan Sanye Pharmaceutical Factory Co., Ltd.
  • Shanghai Xinya Pharmaceutical Minhang Co., Ltd.
  • Southwest Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Rifaximin Capsules Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Rifaximin Capsules Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Rifaximin Capsules Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Rifaximin Capsules Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Rifaximin Capsules Market Dynamics
  1. 2.1 Rifaximin Capsules Industry Trends
  2. 2.2 Rifaximin Capsules Industry Drivers
  3. 2.3 Rifaximin Capsules Industry Opportunities and Challenges
  4. 2.4 Rifaximin Capsules Industry Restraints
3 Rifaximin Capsules Market by Manufacturers
  1. 3.1 Global Rifaximin Capsules Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Rifaximin Capsules Sales by Manufacturers (2021-2026)
  3. 3.3 Global Rifaximin Capsules Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Rifaximin Capsules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Rifaximin Capsules Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Rifaximin Capsules Manufacturers, Product Type & Application
  7. 3.7 Global Rifaximin Capsules Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Rifaximin Capsules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Rifaximin Capsules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Rifaximin Capsules Tier 1, Tier 2, and Tier 3
4 Rifaximin Capsules Market by Type
  1. 4.1 Rifaximin Capsules Type Introduction
  2. 4.1.1 0.1g
  3. 4.1.2 0.2g
  4. 4.2 Global Rifaximin Capsules Sales by Type
  5. 4.2.1 Global Rifaximin Capsules Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Rifaximin Capsules Sales by Type (2021-2032)
  7. 4.2.3 Global Rifaximin Capsules Sales Market Share by Type (2021-2032)
  8. 4.3 Global Rifaximin Capsules Revenue by Type
  9. 4.3.1 Global Rifaximin Capsules Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Rifaximin Capsules Revenue by Type (2021-2032)
  11. 4.3.3 Global Rifaximin Capsules Revenue Market Share by Type (2021-2032)
5 Rifaximin Capsules Market by Application
  1. 5.1 Rifaximin Capsules Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Rifaximin Capsules Sales by Application
  6. 5.2.1 Global Rifaximin Capsules Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Rifaximin Capsules Sales by Application (2021-2032)
  8. 5.2.3 Global Rifaximin Capsules Sales Market Share by Application (2021-2032)
  9. 5.3 Global Rifaximin Capsules Revenue by Application
  10. 5.3.1 Global Rifaximin Capsules Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Rifaximin Capsules Revenue by Application (2021-2032)
  12. 5.3.3 Global Rifaximin Capsules Revenue Market Share by Application (2021-2032)
6 Global Rifaximin Capsules Sales by Region
  1. 6.1 Global Rifaximin Capsules Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Rifaximin Capsules Sales by Region (2021-2032)
  3. 6.2.1 Global Rifaximin Capsules Sales by Region (2021-2026)
  4. 6.2.2 Global Rifaximin Capsules Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Rifaximin Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Rifaximin Capsules Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Rifaximin Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Rifaximin Capsules Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Rifaximin Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Rifaximin Capsules Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Rifaximin Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Rifaximin Capsules Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Rifaximin Capsules Revenue by Region
  1. 7.1 Global Rifaximin Capsules Revenue by Region
  2. 7.1.1 Global Rifaximin Capsules Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Rifaximin Capsules Revenue by Region (2021-2026)
  4. 7.1.3 Global Rifaximin Capsules Revenue by Region (2027-2032)
  5. 7.1.4 Global Rifaximin Capsules Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Rifaximin Capsules Revenue (2021-2032)
  8. 7.2.2 North America Rifaximin Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Rifaximin Capsules Revenue (2021-2032)
  11. 7.3.2 Europe Rifaximin Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Rifaximin Capsules Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Rifaximin Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Rifaximin Capsules Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Rifaximin Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Aden Healthcare
  2. 8.1.1 Aden Healthcare Company Information
  3. 8.1.2 Aden Healthcare Business Overview
  4. 8.1.3 Aden Healthcare Rifaximin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Aden Healthcare Rifaximin Capsules Product Portfolio
  6. 8.1.5 Aden Healthcare Recent Developments
  7. 8.2 Alfasigma SpA
  8. 8.2.1 Alfasigma SpA Company Information
  9. 8.2.2 Alfasigma SpA Business Overview
  10. 8.2.3 Alfasigma SpA Rifaximin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Alfasigma SpA Rifaximin Capsules Product Portfolio
  12. 8.2.5 Alfasigma SpA Recent Developments
  13. 8.3 Estrellas Life Sciences Private Limited
  14. 8.3.1 Estrellas Life Sciences Private Limited Company Information
  15. 8.3.2 Estrellas Life Sciences Private Limited Business Overview
  16. 8.3.3 Estrellas Life Sciences Private Limited Rifaximin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Estrellas Life Sciences Private Limited Rifaximin Capsules Product Portfolio
  18. 8.3.5 Estrellas Life Sciences Private Limited Recent Developments
  19. 8.4 Hainan Hailing Chemical Pharmaceutical Co., Ltd.
  20. 8.4.1 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Company Information
  21. 8.4.2 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Business Overview
  22. 8.4.3 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Rifaximin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Rifaximin Capsules Product Portfolio
  24. 8.4.5 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Recent Developments
  25. 8.5 Hainan Sanye Pharmaceutical Factory Co., Ltd.
  26. 8.5.1 Hainan Sanye Pharmaceutical Factory Co., Ltd. Company Information
  27. 8.5.2 Hainan Sanye Pharmaceutical Factory Co., Ltd. Business Overview
  28. 8.5.3 Hainan Sanye Pharmaceutical Factory Co., Ltd. Rifaximin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hainan Sanye Pharmaceutical Factory Co., Ltd. Rifaximin Capsules Product Portfolio
  30. 8.5.5 Hainan Sanye Pharmaceutical Factory Co., Ltd. Recent Developments
  31. 8.6 Shanghai Xinya Pharmaceutical Minhang Co., Ltd.
  32. 8.6.1 Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Company Information
  33. 8.6.2 Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Business Overview
  34. 8.6.3 Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Rifaximin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Rifaximin Capsules Product Portfolio
  36. 8.6.5 Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Recent Developments
  37. 8.7 Southwest Pharmaceutical Co., Ltd.
  38. 8.7.1 Southwest Pharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Southwest Pharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Southwest Pharmaceutical Co., Ltd. Rifaximin Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Southwest Pharmaceutical Co., Ltd. Rifaximin Capsules Product Portfolio
  42. 8.7.5 Southwest Pharmaceutical Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Rifaximin Capsules Value Chain Analysis
  2. 9.1.1 Rifaximin Capsules Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Rifaximin Capsules Production Mode & Process
  6. 9.2 Rifaximin Capsules Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Rifaximin Capsules Distributors
  9. 9.2.3 Rifaximin Capsules Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst